STAT3 and hepatocellular carcinoma: Studies conducted by Vang et al. demonstrated that STAT3 shRNA-mediated silencing inhibited the proliferation, promoted apoptosis, and cell cycle arrest of HepG2.2.15 HBV+ hepatocellular carcinoma cells [163].